Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
BENZAMIDE DERIVATIVE OR SALT THEREOF
Document Type and Number:
WIPO Patent Application WO/2004/110986
Kind Code:
A1
Abstract:
A compound which functions to inhibit capsaicin receptor VR1 activation and is useful as a therapeutic agent for, e.g., various pains including inflammatory pain and neurogenic pain, migraine, cluster headache, and bladder diseases including overactive bladder. It is a benzamide derivative or salt thereof, the derivative being characterized by comprising: a benzene ring; a ring D (a mono- or dicyclic hydrocarbon ring or mono- or dicyclic heteroaromatic ring) bonded to the benzene ring through an amide bond; a ring E (a mono- or dicyclic hydrocarbon ring or mono- or dicyclic heteroaromatic ring) directly bonded to the benzene ring; and A (an amino moiety or a mono- or dicyclic heteroring) bonded to the benzene ring through L (a lower alkylene).

Inventors:
KURAMOCHI TAKAHIRO (JP)
ASAI NORIO (JP)
IKEGAI KAZUHIRO (JP)
AKAMATSU SEIJIRO (JP)
HARADA HIRONORI (JP)
ISHIKAWA NORIKO (JP)
SHIRAKAMI SHOHEI (JP)
MIYAMOTO SATOSHI (JP)
WATANABE TOSHIHIRO (JP)
KISO TETSUO (JP)
Application Number:
PCT/JP2004/008479
Publication Date:
December 23, 2004
Filing Date:
June 10, 2004
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
YAMANOUCHI PHARMA CO LTD (JP)
KURAMOCHI TAKAHIRO (JP)
ASAI NORIO (JP)
IKEGAI KAZUHIRO (JP)
AKAMATSU SEIJIRO (JP)
HARADA HIRONORI (JP)
ISHIKAWA NORIKO (JP)
SHIRAKAMI SHOHEI (JP)
MIYAMOTO SATOSHI (JP)
WATANABE TOSHIHIRO (JP)
KISO TETSUO (JP)
International Classes:
A61K31/167; A61K31/428; A61K31/4453; A61K31/454; A61K31/4709; A61K31/4725; A61K31/496; A61K31/5377; A61K31/538; A61K31/55; A61P1/04; A61P11/00; A61P11/06; A61P13/10; A61P17/04; A61P25/06; A61P29/00; C07C237/40; C07D209/08; C07D209/34; C07D209/36; C07D213/75; C07D215/38; C07D217/04; C07D223/16; C07D231/56; C07D235/06; C07D241/42; C07D249/18; C07D263/58; C07D265/36; C07D277/62; C07D277/64; C07D277/82; C07D279/16; C07D295/155; C07D307/79; C07D317/64; C07D317/66; C07D333/54; C07D401/12; C07D405/12; C07D409/12; C07D413/12; C07D417/12; C07D417/14; C07D471/04; (IPC1-7): C07C237/40; C07D215/38; C07D217/22; C07D263/58; C07D265/36; C07D277/68; C07D295/14; C07D417/12; A61K31/167; A61K31/428; A61K31/4453; A61K31/454; A61K31/4709; A61K31/4725; A61K31/496; A61K31/5377; A61K31/538; A61K31/55; A61P1/04; A61P11/00; A61P11/06; A61P13/10; A61P17/04; A61P25/06; A61P29/00
Domestic Patent References:
WO2003055848A22003-07-10
WO2003068749A12003-08-21
WO2002008221A22002-01-31
Foreign References:
JP2003055209A2003-02-26
JP2002003370A2002-01-09
Other References:
See also references of EP 1632477A4
Attorney, Agent or Firm:
Morita, Hiroshi c/o Astellas Pharma Inc. (Intellectual Property 3-11, Nihonbashi-Honcho 2-chom, Chuo-ku Tokyo, JP)
Download PDF: